DENTONE, CHIARA
 Distribuzione geografica
Continente #
EU - Europa 9.093
AS - Asia 529
SA - Sud America 73
NA - Nord America 43
AF - Africa 11
Totale 9.749
Nazione #
IT - Italia 9.076
SG - Singapore 234
CN - Cina 133
VN - Vietnam 126
BR - Brasile 48
US - Stati Uniti d'America 28
AR - Argentina 16
HK - Hong Kong 13
MX - Messico 11
ID - Indonesia 7
RU - Federazione Russa 6
BD - Bangladesh 5
EC - Ecuador 4
ZA - Sudafrica 4
NL - Olanda 3
AE - Emirati Arabi Uniti 2
CO - Colombia 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
PY - Paraguay 2
SE - Svezia 2
AT - Austria 1
CZ - Repubblica Ceca 1
DE - Germania 1
EG - Egitto 1
ES - Italia 1
ET - Etiopia 1
GA - Gabon 1
GB - Regno Unito 1
GE - Georgia 1
IN - India 1
IQ - Iraq 1
IR - Iran 1
KE - Kenya 1
KG - Kirghizistan 1
LC - Santa Lucia 1
MD - Moldavia 1
NG - Nigeria 1
NP - Nepal 1
PA - Panama 1
PH - Filippine 1
PK - Pakistan 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 9.749
Città #
Genoa 3.980
Genova 3.095
Rapallo 1.049
Vado Ligure 878
Singapore 62
Beijing 47
Ho Chi Minh City 43
Bordighera 39
Hanoi 32
Hong Kong 13
Ashburn 11
Tianjin 8
Haiphong 7
Mexico City 6
Biên Hòa 5
Hải Dương 5
Denver 4
Milan 4
Bắc Giang 3
Da Nang 3
São Paulo 3
Brasília 2
Campinas 2
Cascina 2
Curitiba 2
Itaquaquecetuba 2
Jakarta 2
Johannesburg 2
Ninh Bình 2
Nova Iguaçu 2
Quito 2
Quảng Ngãi 2
Rio de Janeiro 2
Rome 2
San Juan Bautista 2
Stockholm 2
Sumaré 2
Verona 2
Abu Dhabi 1
Addis Ababa 1
Asunción 1
Açailândia 1
Bab Ezzouar 1
Bagé 1
Balcarce 1
Betim 1
Birmingham 1
Bishkek 1
Boston 1
Buenos Aires 1
Cagayan de Oro 1
Cairo 1
Cajamar 1
Campina Grande 1
Candeias 1
Cao Lanh 1
Cape Town 1
Castries 1
Chengdu 1
Chicago 1
Chisinau 1
Cibitung 1
Ciudad Nezahualcoyotl 1
Clorinda 1
Criciúma 1
Dhaka 1
Divinópolis 1
Duhok 1
Durban 1
Elk Grove Village 1
Esmeraldas 1
Feni 1
Figueira 1
Formosa 1
Fortaleza 1
Gresik 1
Guangzhou 1
Guaíba 1
Ha Long 1
Hermosillo 1
Hurlingham 1
Hyderabad 1
Ilhéus 1
Itabaiana 1
Ituzaingó 1
Jiaxing 1
João Monlevade 1
João Pessoa 1
Juiz de Fora 1
Juárez 1
Kaifeng 1
Kathmandu 1
Katueté 1
Krasnodar 1
Kudus 1
Lagos 1
Lahore 1
Libreville 1
Londrina 1
Long An 1
Totale 9.393
Nome #
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 281
The Ligurian Human Immunodeficiency Virus Clinical Network: A Web Tool to Manage Patients With Human Immunodeficiency Virus in Primary Care and Multicenter Clinical Trials 226
Effectiveness, safety, durability and immune recovery in a retrospective, multicentre, observational cohort of ART-experienced, HIV-1-infected patients receiving maraviroc 209
Budget impact analysis of sofosbuvir-based regimens for the treatment of HIV/HCV-coinfected patients in northern Italy: A multicenter regional simulation 204
A Standard Interface for Data Reuse in Infectious Diseases 190
A Web based tool for antimicrobial resistance evaluation in immunocompromised patient 188
Budget Impact Analysis of Sofosbuvir-Based Regimens for The Treatment of Hiv/Hcv Co-Infected Patients In Northern Italy: The Liguria Region Simulation 181
A comparison of inpatient admissions in 2012 from two European countries 175
Multicentre Clinical Trials’ data management: A hybrid solution to exploit the strengths of Electronic Data Capture and Electronic Health Records systems 171
Bronchoalveolar lavage fluid characteristics and outcomes of invasively mechanically ventilated patients with COVID-19 pneumonia in Genoa, Italy 169
Ricoveri ospedalieri dei pazienti con infezione da HIV in Liguria: risultati preliminari dello studio ACTEA 166
Use of colistin in adult patients: a cross-sectional study 166
Use of maraviroc in clinical practice: a multicenter observational study 165
Inpatient admissions of patients living with HIV in two European centres (UK and Italy); comparisons and contrasts 164
Cost per care of the first year of direct antiviral agents in the liguria region: A multicenter analysis 163
Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19 162
Relationship between innate immunity, soluble markers and metabolic-clinical parameters in HIV+ patients ART treated with HIV-RNA < 50 cp/mL 157
Rete Ligure dell’HIV: due anni di esperienza nella gestione del dato clinico 157
Prevalence and Clinical Significance of Persistent Viral Shedding in Hospitalized Adult Patients with SARS-CoV-2 Infection: A Prospective Observational Study 155
Bloodstream infections in critically ill patients with COVID-19 148
On-field evaluation of a ultra-rapid fluorescence immunoassay as a frontline test for SARS-CoV-2 diagnostic 144
Candida auris Candidemia in Critically Ill, Colonized Patients: Cumulative Incidence and Risk Factors 140
Web interaction to improve collaboration in monitoring of microbial infections 138
Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: Results from a large observational cohort study (SCOLTA) 133
From Liguria HIV Web to Liguria Infectious Diseases Network: How a Digital Platform Improved Doctors' Work and Patients' Care 132
External validation of unsupervised COVID-19 clinical phenotypes and their prognostic impact 130
Control of the HIV-1 DNA reservoir is associated in vivo and in vitro with NKp46/NKp30 (CD335 CD337) inducibility and interferon gamma production by transcriptionally unique NK cells 129
CD8+CD28-CD127loCD39+ T reg: a new biomarker for HIV infection 128
Weight gain: A possible side effect of all antiretrovirals 128
Successful antiretroviral therapy by using unusual antiretroviral combinations in heavily pre-treated patients: two case reports 127
Tocilizumab and steroid treatment in patients with COVID-19 pneumonia 123
Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity 123
Assessment of appropriateness of first-line combined antiretroviral treatment (cART): the preliminary results of Liguria experience V.E.L.A. study 122
LiHlm-Web: a web-application in order to collect, share and analyze immunological data of HIV patients in multicentric studies 120
CD8+CD28-CD127loCD39+Treg Expansion: a New Pathogenic Mechanism for HIV Infection? 118
Successful antiretroviral therapy by using unusual antiretroviral combinations in heavily pre-treated patients: two case reports 116
Prevalence of acquired resistance mutations in a large cohort of perinatally infected HIV-1 patients 113
Valutazione di parametri di immunità innata e di infiammazione correlati ad aspetti clinico-metabolici in una coorte di pazienti HIV positivi con carica virale non rilevabile 111
Genetic polymorphisms of IL28b gene as predictors of response to dual therapy in genotypes 1 and 4-HCV and HIV/HCV-infected patients 109
A very rare case of mycobacterium gordonae infection of the breast 104
Lung distribution of gas and blood volume in critically ill COVID-19 patients: a quantitative dual-energy computed tomography study 104
Early effects of ventilatory rescue therapies on systemic and cerebral oxygenation in mechanically ventilated COVID-19 patients with acute respiratory distress syndrome: a prospective observational study 103
Muscle symptoms and creatine phosphokinase elevations in patients receiving raltegravir in clinical practice: Results from the SCOLTA project long-term surveillance 101
Raltegravir-based therapy in a cohort of HIV/HCV co-infected individuals 100
The impact of liver disease: a leading cause of hospital admissions in people living vith HIV 97
Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study 96
Characterization of T lymphocytes in severe COVID-19 patients 95
Utilizzo di Maraviroc nella pratica clinica: studio multicentrico osservazionale (MARHIV STUDY) 93
Reactivation of Herpes Simplex Virus Type 1 (HSV-1) Detected on Bronchoalveolar Lavage Fluid (BALF) Samples in Critically Ill COVID-19 Patients Undergoing Invasive Mechanical Ventilation: Preliminary Results from Two Italian Centers 92
Early administration of bamlanivimab in combination with etesevimab increases the benefits of covid-19 treatment: Real-world experience from the liguria region 91
Distinct features of immune activation and exhaustion markers in people with perinatally-acquired HIV 90
Una rete multicentrica standardizzata per gestire e analizzare le co-morbidità e gli effetti collaterali legati a terapie HAART in pazienti con infezione da HIV 90
The Ligurian HIV network: How medical informatics standards can help clinical research 89
Use of ceftaroline in hospitalized patients with and without covid-19: A descriptive cross-sectional study 89
A comparative analysis of the first and second COVID-19 wave in Italy: evaluation of mortality in the Infectious Disease Unit of Genoa University Hospital 88
Enterococcal bloodstream infections in critically ill patients with COVID-19: a case series 88
Clinical efficacy of eucaloric ketogenic nutrition in the COVID-19 cytokine storm: A retrospective analysis of mortality and intensive care unit admission 85
Immunological profile of an infant treated with integrase inhibitor from the neonatal period 84
Inflammatory effects of atazanavir/ritonavir versus darunavir/ritonavir in treatment naïve, HIV-1-infected patients 84
Aspergillus-PCR in bronchoalveolar lavage - diagnostic accuracy for invasive pulmonary aspergillosis in critically ill patients 82
T2Bacteria and T2Resistance Assays in Critically Ill Patients with Sepsis or Septic Shock: A Descriptive Experience 82
High-temporal resolution profiling reveals distinct immune trajectories following the first and second doses of COVID-19 mRNA vaccines 81
Spread of carbapenem-resistant gram-negatives and candida auris during the covid-19 pandemic in critically ill patients: One step back in antimicrobial stewardship? 80
Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA project 78
Lipid profile improvement in virologically suppressed hiv-1-infected patients switched to dolutegravir/ abacavir/lamivudine: Data from the SCOLTA project 77
High doses of hydroxychloroquine do not affect viral clearance in patients with SARS-CoV-2 infection 77
Higher mortality and intensive care unit admissions in COVID-19 patients with liver enzyme elevations 77
Lower blood levels of isavuconazole in critically ill patients compared with other populations: possible need for therapeutic drug monitoring 77
Effect of SARS-CoV-2 vaccination in a vulnerable COVID-19 cohort: a real-life experience in an Italian Hospital 76
Healthcare Worker Study Cohort to Determine the Level and Durability of Cellular and Humoral Immune Responses after Two Doses of SARS-CoV-2 Vaccination 76
HCMV-controlling NKG2C+ NK cells originate from novel circulating inflammatory precursors 76
Clinical significance of inflammatory markers of bacterial infection in critically ill patients with COVID-19 after treatment with anti-inflammatory and immunomodulatory drugs: A complex new scenario 74
Short Course of Antifungal Therapy in Patients With Uncomplicated Candida Bloodstream Infection: Another Case of Less Is More in the Clinical Setting? 71
The Longest Persistence of Viable SARS-CoV-2 With Recurrence of Viremia and Relapsing Symptomatic COVID-19 in an Immunocompromised Patient-A Case Study 70
1942. Effect of {SARS}-{CoV}-2 Vaccination in a Frailty {COVID}-19 Cohort: a Real Life Experience in a Northern Italy Hospital 69
Case report: Sotrovimab, remdesivir and nirmatrelvir/ritonavir combination as salvage treatment option in two immunocompromised patients hospitalized for COVID-19 69
Outcome of early treatment of SARS-CoV-2 infection in patients with haematological disorders 68
Clinical presentation of secondary infectious complications in COVID-19 patients in intensive care unit treated with tocilizumab or standard of care 67
Early Clinical Experience with Molnupiravir for Mild to Moderate Breakthrough COVID-19 among Fully Vaccinated Patients at Risk for Disease Progression 65
Behind the screens: Clinical decision support methodologies - A review 65
Triple combination therapy with two antivirals and monoclonal antibodies for persistent or relapsed SARS-CoV-2 infection in immunocompromised patients 62
High prevalence of olfactory and taste disorder during SARS-CoV-2 infection in outpatients 62
Levels of beta-D-glucan in Candida auris supernatants, an in vitro and in vivo preliminary study 60
Prevalence of Viral Hepatitis in Unselected, Consecutively Enrolled Patients Hospitalised for SARS-CoV-2 56
Durability of Dolutegravir-Based Regimens: A 5-Year Prospective Observational Study 56
Neutralizing monoclonal antibodies for the prevention of severe COVID-19: a retrospective study during Omicron BA.1 variant surge 54
Is a step-down antiretroviral therapy necessary to fight severe acute respiratory syndrome coronavirus 2 in HIV-infected patients? 54
Ten Years of Medical Informatics and Standards Support for Clinical Research in an Infectious Diseases Network 50
Factors Associated With Weight Gain in People Treated With Dolutegravir 41
Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy 35
Early and Polyantigenic CD4 T Cell Responses Correlate with Mild Disease in Acute COVID-19 Donors 34
Triple antiviral treatment for COVID-19 in an immunocompromised patient 12
Totale 9.977
Categoria #
all - tutte 39.935
article - articoli 34.923
book - libri 0
conference - conferenze 4.701
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 311
Totale 79.870


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021339 0 0 0 0 0 56 43 49 44 61 36 50
2021/2022789 31 35 38 73 47 46 33 180 70 87 42 107
2022/20231.299 96 134 11 156 147 163 54 86 140 102 187 23
2023/2024832 43 82 16 106 80 171 50 53 34 33 62 102
2024/20252.491 80 146 60 189 251 227 287 501 90 125 286 249
2025/20262.121 555 171 482 317 531 65 0 0 0 0 0 0
Totale 9.977